Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements
Alan P. Venook, MD, describes challenges implementing NCCN guidelines into practice in rectal, colon, and biliary tract cancers, and advancements from 2024.
Related Articles
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
Nature – The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.
AI Software Learns to Identify Pancreatic Cancer Vs Cysts
A computational linguistics model designed to locate pancreatic cysts that started to locate pancreatic cancer has the potential to lead to more efficient treatment.
Understanding Myelodysplastic Syndromes (MDS): Diagnosis, Classification, and Risk Assessment
Panelists discuss how myelodysplastic syndromes are diagnosed, classified, and managed, covering prevalence, symptoms, risk stratification tools, prognosis for lower-risk cases, and current treatment challenges.
When Cancer and Cardiovascular Disease Intersect
The annual Global Cardio-Oncology Summit brings together health-care professionals from diverse disciplines including members of the International Cardio-Oncology Society, the only multidisciplinary p…
ALLO-316 Demonstrates Early Activity and Safety in Advanced CD70-Positive ccRCC
ALLO-316, a CD70-directed CAR T-cell therapy, demonstrated preliminary efficacy and safety in CD70-positive ccRCC.
Midkine at the Crossroads of Aging and Cancer
Abstract. Aging in mammals, including humans, is marked by a multitude of molecular, cellular, and systemic changes that increase the risk of various diseases, including…
Radiology Business Announces Forty Under 40 Class of 2024
Radiology Business Forty Under 40 Class of 2024
Explore the Latest Treatment Updates in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen V. Liu, MD
Hear Chandler Park, MD and Stephen Liu, MD, explore advancements in EGFR-mutated NSCLC treatment, including TKI strategies, emerging therapies prioritizing a patient-centric approach.
Pancreatic Cancer Awareness Month Brings Attention to Growing Incidence and Treatment Advances
Suneel Kamath, MD, took to the OncLive X (Twitter) account during Pancreatic Cancer Awareness Month to share the importance of recognizing this disease.